Nausea, vomiting, diarrhea, and abdominal discomfort remain the most common complaints particularly during the titration phase but most are mild to moderate and decline once a stable dose is reached
Jeff Manley, and the proven effectiveness of our program, you can take the first step towards a healthier, happier you
Tirzepatide (Mounjaro) Indication : Type 2 diabetes (with anticipated obesity indication approval)
Possible note: Because GLP-1 drugs slow stomach emptying, you may absorb pills a little slower but this is not harmful
Science 261:466469 Keller J, Beglinger C, Holst JJ, Andresen V, Layer P (2009) Mechanisms of gastric emptying disturbances in chronic and acute inflammation of the distal gastrointestinal tract